Full List Of Stories
Monday newspaper round-up: Fuel stress, GSK, Boots, Draghi
The number of households suffering from “fuel stress” – those spending at least 10% of their family budgets on energy bills – is set to treble to 6. 3m overnight when the new energy price cap comes in on 1 April, according to a leading research group. Fuel stress will no longer be confined to the poorest households, according to a study by the Resolution Foundation. Low- and middle-income families will also find it hard to cope as they spend a far greater share of their family budget on these essentials than higher earners.
FTSE 250 movers: Cineworld gains; Darktrace takes a hit
London’s FTSE 250 was 0. 6% firmer at 22,868. 49 in afternoon trade on Monday.
FTSE 100 movers: Glaxo surges, Unilever slumps on deal news
London’s FTSE 100 was up 0. 8% at 7,604. 90 in afternoon trade on Monday.
Retail footfall rises as shoppers return to high streets - Springboard
Footfall at UK retail destinations rose last week as shoppers returned to high streets, according to data released on Monday by retail analyst Springboard.
London midday: FTSE maintains gains as Glaxo rallies on deal news
London stocks were still in the black by midday on Monday, with pharmaceuticals giant GlaxoSmithKline pacing the advance after it confirmed it had rejected an offer from Unilever for its consumer healthcare arm.
ITV agrees £500m revolving credit facility linked to emissions targets
Broadcaster ITV said on Monday that it has agreed a new syndicated £500m revolving credit facility linked to its carbon emissions targets.
M&G appoints Kathryn McLeland as CFO
Investment manager M&G said on Monday that it has appointed Kathryn McLeland as chief financial officer.
Darktrace under attack from short seller ShadowFall - report
Shares of Darktrace slid on Monday following a report the cybersecurity firm has come under attack from short seller ShadowFall.
London open: FTSE heads higher; Glaxo paces advance on deal news
London stocks rose in early trade on Monday, with pharmaceuticals giant GlaxoSmithKline pacing the advance after confirming it had rejected an offer from Unilever for its consumer healthcare arm.
UBS ups Antofagasta to 'neutral', says risk/reward more balanced
UBS upgraded Chilean copper miner Antofagasta to ‘neutral’ from ‘sell’ on Monday and lifted the price target to 1,400p from 1,300p as it said the risk/reward was more balanced after recent underperformance.
Ashmore Q2 AUM decline amid weaker emerging markets
Asset manager Ashmore reported a drop in second-quarter assets under management on Monday amid weakness in emerging markets.
London pre-open: Stocks seen up as investors mull China data
London stocks were set to rise at the open on Monday as investors mulled the latest data out of China.